Understanding our integrated model
We developed our integrated model to address our most material matters. The model focuses on the rising cost of healthcare. For most, medical cover has simply become unaffordable. Our mission is to innovate a new integrated model of sustainable healthcare that measurably improves access to quality healthcare. Recognising that we have the scale (with 3.8 million lives under management) and the capability necessary to transform the delivery of healthcare, we set about doing just that.
Over the past few years, the Group has invested significant intellectual capital into analysing the full healthcare spend, analysing the challenges and risk environment and developing or acquiring the necessary assets and capabilities to deliver the right solutions to achieve our mission.
| Aim | Value-adding activity | Outcomes – How we’re increasing the value of the healthcare spend |
||
| PRIMARY CARE | Shifting the focus of healthcare delivery to primary care and prevention or early detection to increase access to sustainable, affordable and quality healthcare. |
At the core of AfroCentric's offering is Medscheme, who:
|
2.4% of scheme lives are responsible for 16% of scheme claims. Effective management of the care and lifestyle factors of these people is core to our strategy.Medscheme managed care pilots conducted by multi-disciplinary clinical teams for integrated chronic care, healthcare outcomes and value-linked reimbursement, resulted in:
|
|
Allegra leverages technology to reduce cost and improve patient experience with:
|
Allegra's cost-saving healthcare technology has:
|
|||
| EssentialMed provides medical insurance focused on primary care that widens the range of affordable products available to employees and scheme members. | EssentialMed's products and services retain members who would otherwise not be able to afford medical aid. | |||
| AfroCentric Integrated Corporate Solutions delivers integrated health and wellness solutions for the workplace. | Value delivered includes:
|
|||
| Aim | Value-adding activity | Outcomes – How we’re increasing the value of the healthcare spend |
|||||||||||||||||||||||||||||||||||||
| MEDICINE AND MEDICAL PRODUCTS | |||||||||||||||||||||||||||||||||||||||
| Participating throughout the pharmaceutical value chain to reduce medicine and related costs. |
MMed eliminates the need for third-party suppliers to hospitals. |
|
|||||||||||||||||||||||||||||||||||||
| Activo Health acquires the rights to distribute affordable generic medicine for managing chronic and acute conditions. | |||||||||||||||||||||||||||||||||||||||
| Pharmacy Direct increases access to healthcare and alleviates congestion in public hospitals and clinics by distributing chronic medicine to provincial hospitals countrywide (80% of public sector work). As a courier pharmacy, Pharmacy Direct also distributes chronic medication to medical scheme members. | |||||||||||||||||||||||||||||||||||||||
| Curasana plays a pivotal role in managing the pharmaceutical value chain by ensuring that stock demands are met for its clients to ensure the continuation of chronic treatment for patients. | |||||||||||||||||||||||||||||||||||||||
| Scriptpharm delivers a unique chronic medicine capitation solution through a network of over 2 000 retail pharmacies and has diversified into oncology and acute medicine where it reduces costs by increasing the use of generic medicine. | |||||||||||||||||||||||||||||||||||||||
| SPECIALIST CARE AND HOSPITALISATION | Negotiating strategic purchasing arrangements to eliminate inefficiency and contain hospital costs.Negotiating arrangements to reduce the length of hospital stays and improve cost-efficiency of treatment, while ensuring quality patient care and appropriate remuneration for specialists. |
Medscheme improves healthcare providers' efficiencies and reduces costs with:
|
Containing the hospital costs by reducing the elements that drive costs (fewer people coming into hospital, staying in hospitals briefly and managing post-discharge care to prevent readmissions)
|
||||||||||||||||||||||||||||||||||||
| Klinnika’s DBC for musculoskeletal disorders helps insurance providers and employers to make informed choices when evaluating scheme members with back and neck pain, reducing the cost of care by limiting unnecessary hospitalisation and surgery. | |||||||||||||||||||||||||||||||||||||||
| Aid for AIDS’s clinical guidelines achieve effective viral load suppression, resulting in fewer hospital admissions. | |||||||||||||||||||||||||||||||||||||||
| Aim | Value-adding activity | Outcomes – How we’re increasing the value of the healthcare spend |
||
| ACROSS THE ENTIRE CARE CYCLE | Curbing FWA with analytics. Leveraging digital technology to enhance client experience. |
Medscheme applies a fraud risk management system with sophisticated analytical measures to identify and curb unethical behaviour and reinforce the principles of ethical billing and claims behaviour in the provision of services to medical scheme members. These include:
|
FWA prevention as at 30 June 2020:
|
|
Digital priorities for the Group include:
|
|
|||






